CMB International Securities Raises NEWBORNTOWN (09911) Target Price to HK$16 and Maintains "Buy" Rating

Stock News
Sep 02, 2025

CMB International Securities released a research report stating that NEWBORNTOWN (09911) shares have surged 231% year-to-date. The company's current valuation stands at 10x price-to-earnings ratio for the next 12 months and 0.5x PEG ratio, compared to Chinese internet peers' average of 16.5x P/E and 1.2x PEG, and US peers' average of 24x P/E and 1.5x PEG.

The firm raised its target price for NEWBORNTOWN from HK$12.2 to HK$16.2, corresponding to 17x and 14x P/E ratios for fiscal years 2025 and 2026 respectively, while maintaining its "Buy" rating.

The report highlighted that NEWBORNTOWN's first-half performance exceeded expectations. Revenue grew 40% year-over-year to RMB 3.18 billion, meeting forecasts, with social and innovation business revenues increasing 37% and 72% respectively.

Group gross profit surged 56% year-over-year, exceeding expectations by 10%, with gross margin reaching 55.8%, up 5.6 percentage points year-over-year. This improvement was primarily driven by the innovation business gross margin rising significantly from 55% to 74%, boosted by incremental contributions from "Alice's Fantasy Adventure," while social business gross margin increased 3.8 percentage points year-over-year to 54%.

Adjusted operating profit and net profit grew 51% and 137% respectively year-over-year, surpassing expectations by 13% and 23%, benefiting from prudent cost control, operational leverage effects, and minority stake acquisitions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10